rs6435068

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_032977.4(CASP10):​c.1415+2163T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 152,188 control chromosomes in the GnomAD database, including 2,519 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 2519 hom., cov: 32)

Consequence

CASP10
NM_032977.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.95

Publications

4 publications found
Variant links:
Genes affected
CASP10 (HGNC:1500): (caspase 10) This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8. Mutations in this gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CASP10 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2A
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032977.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.336 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032977.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP10
NM_032977.4
MANE Select
c.1415+2163T>C
intron
N/ANP_116759.2
CASP10
NM_032974.5
c.1415+2163T>C
intron
N/ANP_116756.2
CASP10
NM_001230.5
c.1286+2163T>C
intron
N/ANP_001221.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP10
ENST00000286186.11
TSL:1 MANE Select
c.1415+2163T>C
intron
N/AENSP00000286186.6Q92851-4
CASP10
ENST00000448480.1
TSL:1
c.1286+2163T>C
intron
N/AENSP00000396835.1Q92851-5
CASP10
ENST00000313728.12
TSL:1
c.1214+2163T>C
intron
N/AENSP00000314599.7Q92851-6

Frequencies

GnomAD3 genomes
AF:
0.124
AC:
18813
AN:
152070
Hom.:
2498
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.340
Gnomad AMI
AF:
0.00769
Gnomad AMR
AF:
0.0571
Gnomad ASJ
AF:
0.0913
Gnomad EAS
AF:
0.00366
Gnomad SAS
AF:
0.0615
Gnomad FIN
AF:
0.0327
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0397
Gnomad OTH
AF:
0.0886
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.124
AC:
18889
AN:
152188
Hom.:
2519
Cov.:
32
AF XY:
0.121
AC XY:
8994
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.340
AC:
14099
AN:
41442
American (AMR)
AF:
0.0570
AC:
872
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0913
AC:
317
AN:
3472
East Asian (EAS)
AF:
0.00366
AC:
19
AN:
5186
South Asian (SAS)
AF:
0.0609
AC:
294
AN:
4826
European-Finnish (FIN)
AF:
0.0327
AC:
347
AN:
10620
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0397
AC:
2700
AN:
68026
Other (OTH)
AF:
0.0962
AC:
203
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
687
1373
2060
2746
3433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0930
Hom.:
187
Bravo
AF:
0.131
Asia WGS
AF:
0.0740
AC:
256
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.53
DANN
Benign
0.46
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6435068;
hg19: chr2-202076448;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.